Concord Drugs Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹11.69Cr |
Net Profits | ₹0.03Cr |
Net Profit Margins | 0.26% |
Highlights
Revenue:
Concord Drugs Ltd’s revenue jumped 30.18% since last year same period to ₹11.69Cr in the Q1 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated -25.26% fall in its revenue since last 3-months.
Net Profits:
Concord Drugs Ltd’s net profit fell -93.88% since last year same period to ₹0.03Cr in the Q1 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 108.82% jump in its net profits since last 3-months.
Net Profit Margins:
Concord Drugs Ltd’s net profit margin fell -95.3% since last year same period to 0.26% in the Q1 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 111.8% jump in its net profit margins since last 3-months.
